Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Schizophrenia is associated with increased cardiovascular disease morbidity and mortality. Schizophrenia is also associated with immune and inflammatory abnormalities, including aberrant blood levels of lymphocytes, cytokines and high-sensitivity C-reactive protein (hsCRP). The purpose of this study is to investigate the relationship between total and differential white blood cell (WBC) counts, hsCRP, and indices of cardiovascular disease risk in patients with schizophrenia and related non-affective psychoses. 108 inpatients and outpatients age 18–70 with non-affective psychoses and 44 controls participated in this cross-sectional study. Subjects had a fasting blood draw between 8 and 9 am for glucose, lipids, total and differential WBC counts, and hsCRP. Vital signs and medical history were obtained. Patients with non-affective psychosis had significantly higher hsCRP levels than controls (p=0.04). In linear regression analyses, lymphocyte and monocyte counts were a significant predictor of the total-to-HDL cholesterol ratio in subjects with non-affective psychosis (p≤0.02 for each). In binary logistic regression analyses, total WBC count was a significant predictor of an elevated 10-year estimated risk of myocardial infarction and cardiovascular disease in subjects with non-affective psychosis (p≤0.03 for each). Associations between total and differential WBC counts and cardiovascular disease risk indices were stronger in males than females with non-affective psychosis. Our findings provide further evidence that measurement of total and differential WBC counts may be germane to the clinical care of patients with schizophrenia and related disorders, and support an association between inflammation and cardiovascular disease risk in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2010) · The Lancet · doi:10.1016/s0140-6736(09)61717-7 · Cited by 2,546 · cited 1×
“A meta-analysis found that the acute phase inflammatory marker high-sensitivity CRP (hsCRP) was an independent predictor of cardiovascular disease (Kaptoge et al., 2010).”
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065 · cited 1×
“Introduction Cardiovascular disease is the leading cause of death in patients with schizophrenia and related disorders, and premature mortality is dramatically increased in this patient population (Brown 1997; Harris and Barraclough, 1998; Miller et al., 2006, Saha et al., 2007).”
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881 · cited 2×
“Cardiovascular disease is the leading cause of death in patients with schizophrenia and related disorders, and premature mortality is dramatically increased in this patient population (Brown, 1997; Harris and Barraclough, 1998; Miller et al., 2006; Saha et al., 2007).”
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742 · cited 3×
“, 2013a,b), cytokines (Miller et al., 2011) and hsCRP (Miller et al.”
InfluentialSelf-citationExcess mortality of schizophrenia: A meta-analysis
Brown, S. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.6.502 · Cited by 869
Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., Lamberti, S., D'Agostino, R. B., Stroup, T. S., Davis, S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.010 · Cited by 528
Mitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & De Hert, M. (2012) · Psychological Medicine · doi:10.1017/s003329171100105x · Cited by 332 · cited 1×
“Despite the American Diabetes Association/American Psychiatric Association consensus guidelines for metabolic monitoring of patients on antipsychotic drugs (2004), monitoring rates in clinical practice remain alarmingly low (Mitchell et al., 2012).”
BackgroundMortality and Medical Comorbidity Among Patients With Serious Mental Illness
Miller, B. J., Paschall, C. B., & Svendsen, D. P. (2006) · Psychiatric Services · doi:10.1176/ps.2006.57.10.1482 · Cited by 275
Self-citation
Cited by
Neutrophil-to-lymphocyte ratio in schizophrenia: A systematic review and meta-analysis
Karageorgiou, V., Milas, G. P., & Michopoulos, I. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2018.12.017 · Cited by 163
Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups
Joseph, J., Depp, C., Martin, A. S., Daly, R. E., Glorioso, D. K., Palmer, B. W., & Jeste, D. V. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.08.019 · Cited by 109
“For example, schizophrenia is associated with increased risk of higher bodymass index (BMI) (Lopresti and Drummond, 2013) and cardiovascular disease (Jin et al., 2011; Miller et al., 2015; Sicras-Mainar et al., y C-reactive protein levels in schizophrenia and comparison groups, 2013).”
Bergmans, R. S., Kelly, K. M., & Mezuk, B. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.046 · Cited by 50
“More recently, a meta-analysis (Black and Miller, 2015) and a study of 52 patients with MD (Cáceda et al., 2018) also concluded that while CRP may identify those with MD from non-psychiatric controls, it does not appear to distinguish suicide ideation among patients with MD (Black and Miller, 2015;…”
BackgroundInfluentialBlood cell count in antipsychotic-naive patients with non-affective psychosis
Garcia‐Rizo, C., Casanovas, M., Fernandez‐Egea, E., Oliveira, C., Meseguer, A., Cabrera, B., Mezquida, G., Bioque, M., Kirkpatrick, B., & Bernardo, M. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12456 · Cited by 43
“Increased WBC has been described related not only to medical conditions, metabolic syndrome or CVD risk (Miller, Kandhal, Rapaport, Mellor, & Buckley, 2015) but also to psychopathological conditions, such a more severe clinical symptomatology (Fan et al., 2010).”
BackgroundInfluentialA probe in the connection between inflammation, cognition and suicide
Cáceda, R., Griffin, W. S. T., & Delgado, P. L. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118764022 · Cited by 30
Metadata
- Authors
- Miller, B. J., Kandhal, P., Rapaport, M. H., Mellor, A., & Buckley, P.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 45
- Pages
- 28-35
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W2008884291
- Cited by
- 31
- References
- 8
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses. https://app.cochat.ai/papers/10.1016/j.bbi.2014.12.005
- The paper
- Miller, B. J., Kandhal, P., Rapaport, M. H., Mellor, A., & Buckley, P. (2015). Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2014.12.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.